With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.166330-10-5,(Oxybis(2,1-phenylene))bis(diphenylphosphine),as a common compound, the synthetic route is as follows.
General procedure: A mixture of 0.0630 g [Cu(CH3CN)4]BF4 (0.2 mmol), 0.0464 gdpq (0.2 mmol) and 0.1157 g xantphos (0.2 mmol) were dissolved in the mixed solvents of 5 mL CH3OH and 5 mL CH2Cl2, stirred atroom temperature for 6 h. The filtrate was evaporated slowly at room temperature for around 4 days to yield yellow crystalline products. Yield: 80%. Anal. Calc. for C55H49BCuF4N4O3.50P2: C,63.87; H, 4.78; N, 5.42. Found: C, 65.11; H, 4.16; N, 5.76%., 166330-10-5
As the paragraph descriping shows that 166330-10-5 is playing an increasingly important role.
Reference£º
Article; Kuang, Xiao-Nan; Lin, Sen; Liu, Jian-Ming; Han, Hong-Liang; Liu, Min; Xin, Xiu-Lan; Yang, Yu-Ping; Li, Zhong-Feng; Jin, Qiong-Hua; Li, Si-Fan; Li, Yue-Xue; Feng, Yue-Bing; Polyhedron; vol. 165; (2019); p. 51 – 62;,
Phosphine ligand
Chiral phosphine ligands in asymmetric synthesis. Molecular structure and absolute configuration of (1,5-cyclooctadiene)-(2S,3S)-2,3-bis(diphenylphosphino)butanerhodium(I) perchlorate tetrahydrofuran solvate